Journal Logo

Most Popular Articles

Improved Tumor Purity Metrics in Next-generation Sequencing for Clinical Practice: The Integrated Interpretation of Neoplastic Cellularity and Sequencing Results (IINCaSe) Approach

Patel, Nirali M.; Jo, Heejoon; Eberhard, David A.; More

Applied Immunohistochemistry & Molecular Morphology. 27(10):764-772, November/December 2019.

A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non–Small Cell Lung Cancer

Taylor, Clive R.; Jadhav, Anagha P.; Gholap, Abhi; More

Applied Immunohistochemistry & Molecular Morphology. 27(4):263-269, April 2019.

Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies

Hicks, David; Dell’Orto, Patrizia; Falzon, Mary; More

Applied Immunohistochemistry & Molecular Morphology. 25(5):313-319, May/June 2017.

Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab

Vennapusa, Bharathi; Baker, Brian; Kowanetz, Marcin; More

Applied Immunohistochemistry & Molecular Morphology. 27(2):92-100, February 2019.

Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)

Cheung, Carol C.; Barnes, Penny; Bigras, Gilbert; More

Applied Immunohistochemistry & Molecular Morphology. 27(10):699-714, November/December 2019.

BRAF and NRAS Mutations are Heterogeneous and Not Mutually Exclusive in Nodular Melanoma

Chiappetta, Caterina; Proietti, Ilaria; Soccodato, Valentina; More

Applied Immunohistochemistry & Molecular Morphology. 23(3):172-177, March 2015.

Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision

Georgescu, Rares; Boros, Monica; Moncea, Denisa; More

Applied Immunohistochemistry & Molecular Morphology. 26(8):533-538, September 2018.

Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung Cancer

Roach, Charlotte; Zhang, Nancy; Corigliano, Ellie; More

Applied Immunohistochemistry & Molecular Morphology. 24(6):392-397, July 2016.

Hematoxylin and Eosin Counterstaining Protocol for Immunohistochemistry Interpretation and Diagnosis

Grosset, Andrée-Anne; Loayza-Vega, Kevin; Adam-Granger, Éloïse; More

Applied Immunohistochemistry & Molecular Morphology. 27(7):558-563, August 2019.

Development of an Immunohistochemical Assay to Detect the Ataxia-Telangiectasia Mutated (ATM) Protein in Gastric Carcinoma

Miller, Rachel M.; Nworu, Chinedu; McKee, Laurel; More

Applied Immunohistochemistry & Molecular Morphology. 28(4):303-310, April 2020.

Metastatic Renal Cell Carcinoma to the Brain: A Contemporary Clinicopathologic Analysis With Comparison of Immunohistochemical Profiles to Selected Primary Brain Tumors With Clear Cell Features

Zheng, Wei; Goodman, Abigail L.; Velázquez Vega, José E.; More

Applied Immunohistochemistry & Molecular Morphology. 28(5):395-402, May/June 2020.

Storage Conditions and Immunoreactivity of Breast Cancer Subtyping Markers in Tissue Microarray Sections

Omilian, Angela R.; Zirpoli, Gary R.; Cheng, Ting-Yuan David; More

Applied Immunohistochemistry & Molecular Morphology. 28(4):267-273, April 2020.

Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation Sequencing

Murphy, Danielle A.; Ely, Heather A.; Shoemaker, Robert; More

Applied Immunohistochemistry & Molecular Morphology. 25(7):513-523, August 2017.

Overexpression of β3 Chains of Laminin-332 is Associated With Clinicopathologic Features and Decreased Survival in Patients With Pancreatic Adenocarcinoma

Chen, Jun; Wang, Weilin; Wei, Jianfeng; More

Applied Immunohistochemistry & Molecular Morphology. 23(7):516-521, August 2015.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories

Torlakovic, Emina E.; Cheung, Carol C.; D’Arrigo, Corrado; More

Applied Immunohistochemistry & Molecular Morphology. 25(3):151-159, March 2017.

Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization

Mathiak, Micaela; Warneke, Viktoria S.; Behrens, Hans-Michael; More

Applied Immunohistochemistry & Molecular Morphology. 25(1):12-24, January 2017.

Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer

Birtalan, Ede; Danos, Kornel; Gurbi, Bianka; More

Applied Immunohistochemistry & Molecular Morphology. 26(7):e79-e85, August 2018.

Expression of 6 Common Antigenic Markers in Invasive Ductal Breast Carcinoma: Potential Clinical Implications

Lialiaris, Theodore S.; Kouskoukis, Alexandros; Georgiou, Georgios; More

Applied Immunohistochemistry & Molecular Morphology. 19(2):106-111, March 2011.

NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRASQ61R or KRASQ61R Mutation in Colorectal Carcinoma

Turchini, John; Andrici, Juliana; Sioson, Loretta; More

Applied Immunohistochemistry & Molecular Morphology. 25(7):475-480, August 2017.

S100 Staining Adds to the Prognostic Significance of the Combination of Perineural Invasion and Lymphovascular Invasion in Colorectal Cancer

Conte, Gabriella A.; Qari, Omar; Fasano, Genevieve A.; More

Applied Immunohistochemistry & Molecular Morphology. 28(5):354-359, May/June 2020.

Using Immunohistochemistry Without Linkers to Determine the Optimum Concentrations of Primary Antibodies for Immunofluorescence Staining of Formalin-fixed Paraffin-embedded Tissue Sections

Lugos, Moses D.; Davou, Gwom I.; Choji, Tobias P.P.; More

Applied Immunohistochemistry & Molecular Morphology. 28(3):249-257, March 2020.

Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology

Nottegar, Alessia; Tabbò, Fabrizio; Luchini, Claudio; More

Applied Immunohistochemistry & Molecular Morphology. 26(6):383-387, July 2018.

Show: